pT2-shATRX-GFP Citations (1)
Originally described in: IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.Nunez FJ, Mendez FM, Kadiyala P, Alghamri MS, Savelieff MG, Garcia-Fabiani MB, Haase S, Koschmann C, Calinescu AA, Kamran N, Saxena M, Patel R, Carney S, Guo MZ, Edwards M, Ljungman M, Qin T, Sartor MA, Tagett R, Venneti S, Brosnan-Cashman J, Meeker A, Gorbunova V, Zhao L, Kremer DM, Zhang L, Lyssiotis CA, Jones L, Herting CJ, Ross JL, Hambardzumyan D, Hervey-Jumper S, Figueroa ME, Lowenstein PR, Castro MG Sci Transl Med. 2019 Feb 13;11(479). pii: 11/479/eaaq1427. doi: 10.1126/scitranslmed.aaq1427. PubMed Journal
Articles Citing pT2-shATRX-GFP
| Articles |
|---|
| H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models. Haase S, Banerjee K, Mujeeb AA, Hartlage CS, Nunez FM, Nunez FJ, Alghamri MS, Kadiyala P, Carney S, Barissi MN, Taher AW, Brumley EK, Thompson S, Dreyer JT, Alindogan CT, Garcia-Fabiani MB, Comba A, Venneti S, Ravikumar V, Koschmann C, Carcaboso AM, Vinci M, Rao A, Yu JS, Lowenstein PR, Castro MG. J Clin Invest. 2022 Nov 15;132(22):e154229. doi: 10.1172/JCI154229. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.